Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Munich - Delayed Quote • EUR AnaptysBio Inc (AN6.MU) Follow Compare 16.80 +1.20 +(7.69%) At close: April 17 at 8:00:14 AM GMT+2 Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for AN6.MU 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: AN6.MU View More All News Press Releases SEC Filings Bright Peak Therapeutics Appoints John Schmid to its Board of Directors AnaptysBio (ANAB) Moves 9.5% Higher: Will This Strength Last? Anaptys Announces Stock Repurchase Plan Wells Fargo Predicts Up to ~440% Rally for These 2 ‘Strong Buy’ Stocks AnaptysBio, Inc. (ANAB) Reports Q4 Loss, Tops Revenue Estimates Anaptys Announces Participation in March Investor Conferences Anaptys Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update Truist says AnaptysBio handing of placebo ‘raise doubt’ about Phase 2 RA data Is AnaptysBio (ANAB) Stock Outpacing Its Medical Peers This Year? AnaptysBio (ANAB) Surges 30.5%: Is This an Indication of Further Gains? AnaptysBio achieves ‘highest ever’ results in Phase II rheumatoid arthritis trial